Chargement en cours...
ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN/PI3K/AKT signalling pathway by combining with P53
Acute myeloid leukaemia is a complex, highly aggressive hematopoietic disorder. Currently, in spite of great advances in radiotherapy and chemotherapy, the prognosis for AML patients with initial treatment failure is still poor. Therefore, the need for novel and efficient therapies to improve AML tr...
Enregistré dans:
| Publié dans: | J Cell Mol Med |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8178252/ https://ncbi.nlm.nih.gov/pubmed/33960640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.16539 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|